Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dietmar Gross

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Cancer Research and Clinical Oncology|June 1, 2006
Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activityDietmar Gross, Günther Bernhardt, Armin Buschauer
Cancer Chemotherapy and Pharmacology|May 17, 2006
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cellsChristine Müller, Dietmar Gross, Vasiliki Sarli, et al.
Drug Discovery Today|January 19, 2016
Translational Medicine Guide transforms drug development processes: the recent Merck experienceHugues Dolgos, Mark Trusheim, Dietmar Gross, et al.
Chembiochem : a European Journal of Chemical Biology|September 19, 2007
Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonistErich Schneider, Max Keller, Albert Brennauer, et al.
Bioorganic & Medicinal Chemistry|May 30, 2007
Antimitotic activities of 2-phenylindole-3-carbaldehydes in human breast cancer cellsDoris Kaufmann, Michaela Pojarová, Susanne Vogel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Cancer Research and Clinical Oncology|June 1, 2006
Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activityDietmar Gross, Günther Bernhardt, Armin Buschauer
Cancer Chemotherapy and Pharmacology|May 17, 2006
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cellsChristine Müller, Dietmar Gross, Vasiliki Sarli, et al.
Drug Discovery Today|January 19, 2016
Translational Medicine Guide transforms drug development processes: the recent Merck experienceHugues Dolgos, Mark Trusheim, Dietmar Gross, et al.
Chembiochem : a European Journal of Chemical Biology|September 19, 2007
Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonistErich Schneider, Max Keller, Albert Brennauer, et al.
Bioorganic & Medicinal Chemistry|May 30, 2007
Antimitotic activities of 2-phenylindole-3-carbaldehydes in human breast cancer cellsDoris Kaufmann, Michaela Pojarová, Susanne Vogel, et al.
Pageof 1